Azilsartan + Cilnidipine Tablet
Azilsartan + Cilnidipine Tablet
Azilsartan + Cilnidipine — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — Angiotensin II receptor blocker + Dual L/N-type calcium channel blocker
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Azilsartan + Cilnidipine Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Essential hypertension, alone or with other antihypertensives
- Combination with calcium channel blockers such as cilnidipine for better control
- Combination with ARBs such as azilsartan or telmisartan for better control
Mechanism of Action
Azilsartan — Azilsartan, given as the prodrug azilsartan medoxomil, selectively blocks angiotensin II type 1 (AT1) receptors. This prevents vasoconstriction and aldosterone release, lowering blood pressure.
Cilnidipine — Cilnidipine blocks L-type calcium channels in vascular smooth muscle, causing vasodilation, and N-type channels at sympathetic nerve endings, reducing noradrenaline release. This lowers blood pressure with relatively little reflex tachycardia.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Azilsartan + Cilnidipine Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Dizziness
- Diarrhoea
- Low blood pressure
- Headache
- Flushing
Contraindications
- Known hypersensitivity to any component of the formulation
- Pregnancy: contraindicated; can harm the unborn baby
- Do not combine with aliskiren in diabetes or renal impairment
- Cardiogenic shock or severe aortic stenosis
- Pregnancy and breastfeeding
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Azilsartan + Cilnidipine Tablet
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Azilsartan + Cilnidipine. It is a fixed-dose combination of angiotensin II receptor blocker and dual L/N-type calcium channel blocker, used for essential hypertension, alone or with other antihypertensives and combination with ARBs such as azilsartan or telmisartan for better control. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Azilsartan + Cilnidipine Tablet brings together Azilsartan (angiotensin II receptor blocker) and Cilnidipine (dual L/N-type calcium channel blocker) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Azilsartan + Cilnidipine Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Azilsartan + Cilnidipine Tablet in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Azilsartan + Cilnidipine Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Azilsartan + Cilnidipine Tablet used for?
Azilsartan + Cilnidipine Tablet is used for essential hypertension, alone or with other antihypertensives; combination with calcium channel blockers such as cilnidipine for better control; combination with ARBs such as azilsartan or telmisartan for better control. It should be used as advised by a registered medical practitioner.
Is Azilsartan + Cilnidipine Tablet available for PCD pharma franchise on monopoly basis?
Yes. Azilsartan + Cilnidipine Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Azilsartan + Cilnidipine for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Azilsartan + Cilnidipine Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Azilsartan + Cilnidipine Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Azilsartan + Cilnidipine?
Azilsartan + Cilnidipine is a fixed-dose combination of angiotensin II receptor blocker and dual L/N-type calcium channel blocker (therapeutic class: Fixed-Dose Combination — Angiotensin II receptor blocker + Dual L/N-type calcium channel blocker).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Azilsartan + Cilnidipine Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Azilsartan + Cilnidipine Tablet?